Treatment Options for Renal Cell Cancer
A link to a list of current clinical trials is included for each treatment section. For some types or stages of cancer, there may not be any trials listed. Check with your doctor for clinical trials that are not listed here but may be right for you.
Stage I Renal Cell Cancer
General Information About Transitional Cell Cancer of the Renal Pelvis and Ureter
Transitional cell cancer of the renal pelvis and ureter is a disease in which malignant (cancer) cells form in the renal pelvis and ureter. The renal pelvis is part of the kidney and the ureter connects the kidney to the bladder. There are 2 kidneys, one on each side of the backbone, above the waist. The kidneys of an adult are about 5 inches long and 3 inches wide and are shaped like a kidney bean. The kidneys clean the blood and produce urine to rid the body of waste. The urine collects in the...
Treatment of stage I renal cell cancer may include the following:
- Surgery (radical nephrectomy, simple nephrectomy, or partial nephrectomy).
- Radiation therapy as palliative therapy to relieve symptoms in patients who cannot have surgery.
- Arterial embolization as palliative therapy.
- A clinical trial of a new treatment.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with stage I renal cell cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.
Stage II Renal Cell Cancer
Treatment of stage II renal cell cancer may include the following:
- Surgery (radical nephrectomy or partial nephrectomy).
- Surgery (nephrectomy), before or after radiation therapy.
- Radiation therapy as palliative therapy to relieve symptoms in patients who cannot have surgery.
- Arterial embolization as palliative therapy.
- A clinical trial of a new treatment.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with stage II renal cell cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.
Stage III Renal Cell Cancer
Treatment of stage III renal cell cancer may include the following:
- Surgery (radical nephrectomy). Blood vessels of the kidney and some lymph nodes may also be removed.
- Arterial embolization followed by surgery (radical nephrectomy).
- Radiation therapy as palliative therapy to relieve symptoms and improve the quality of life.
- Arterial embolization as palliative therapy.
- Surgery (nephrectomy) as palliative therapy.
- Radiation therapy before or after surgery (radical nephrectomy).
- A clinical trial of biologic therapy following surgery.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with stage III renal cell cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.
Stage IV and Recurrent Renal Cell Cancer
Treatment of stage IV and recurrentrenal cell cancer may include the following:
- Surgery (radical nephrectomy).
- Surgery (nephrectomy) to reduce the size of the tumor.
- Targeted therapy.
- Biologic therapy.
- Radiation therapy as palliative therapy to relieve symptoms and improve the quality of life.
- A clinical trial of a new treatment.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with stage IV renal cell cancer and recurrent renal cell cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.
WebMD Public Information from the National Cancer Institute

